Non-tuberculous mycobacterial infection in cystic fibrosis before and after initiation of elexacaftor/tezacaftor/ivacaftor: now is not the time to lower the guard

Background The prevalence of infection with non-tuberculous mycobacteria (NTM) has been increasing in people with cystic fibrosis (pwCF) over the past 30 years. Emerging reports of beneficial effects of CFTR modulators, particularly elexacaftor/tezacaftor/ivacaftor (ETI), on the rates of NTM acquisi...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Philip Masel, Rachel M Thomson, Daniel Smith, David W Reid, Daniel Henderson, Vanessa Moore, Timothy Riddles, Ieuan Edward Shepherd Evans, Andrew J Burke
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMJ Publishing Group 2025-12-01
סדרה:	BMJ Open Respiratory Research
גישה מקוונת:	https://bmjopenrespres.bmj.com/content/12/1/e003204.full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!